
Gamot API is the holding company of Sekhmet Pharmaventures Pvt. Ltd., an investment platform formed by Asian private equity major PAG, based in Singapore, along with Indian private equity firms CX Partners and Samara Capital, to buy stakes in fast-growing Indian pharma companies. Sekhmet Pharmaventures, Gamot API's Indian subsidiary, acquired a major stake in Chennai-based Anjan Drug Pvt. Ltd. in October 2020 and subsequently acquired a major stake in the Optimus Drugs Group of Companies in May 2022, planning to invest in multiple manufacturing facilities dedicated to APIs and formulations as India becomes an increasingly important part of the global supply chain amid shifting geopolitical dynamics.

Aucun commentaire disponible.
Laissez votre note & commentaire